SPONSOR
Second Xiangya Hospital of Central South University
Total Trials
7
Recruiting
7
Phases
Phase 1
Conditions studied: Lung CancerSleep DisturbanceImmune Checkpoint InhibitorsCancer, Treatment-RelatedLung Cancer, Non-small CellEGFR Gene MutationEGFR-TKI Resistant MutationPrimary ResistanceCirculating Tumor DNAType 1 Diabetes
Second Xiangya Hospital of Central South University is a clinical research sponsor with 7 registered studies on ClinicalTrials.gov, of which 7 are actively recruiting participants. Research covers conditions including Lung Cancer, Sleep Disturbance, Immune Checkpoint Inhibitors, Cancer, Treatment-Related.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Second Xiangya Hospital of Central South University
How many clinical trials has Second Xiangya Hospital of Central South University sponsored?
ClinicalMetric currently tracks 7 clinical trials sponsored by Second Xiangya Hospital of Central South University, of which 7 are actively recruiting participants. These trials cover conditions including Lung Cancer, Sleep Disturbance, Immune Checkpoint Inhibitors. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Second Xiangya Hospital of Central South University research focus on?
Second Xiangya Hospital of Central South University clinical trials span Lung Cancer, Sleep Disturbance, Immune Checkpoint Inhibitors, Cancer, Treatment-Related, Lung Cancer, Non-small Cell, and additional conditions. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Second Xiangya Hospital of Central South University clinical trial?
To participate in a Second Xiangya Hospital of Central South University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Second Xiangya Hospital of Central South University trials with current recruitment status updated daily.
Clinical Trials by Second Xiangya Hospital of Central South University
NCT06975384
Recruiting
The Associations of Sleep Disturbance With Therapy Efficacy and Prognosis of Lung Cancer
Lung Cancer
NCT05598528
Recruiting
Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study)
Lung Cancer, Non-small Cell
NCT06496412
Recruiting
Safety and Efficacy of Fecal Microbiota Transplantation on Cognitive Function in T1DM
Type 1 Diabetes
NCT05593081
Recruiting
Multicenter Study of Fulminant Type 1 Diabetes in China
Diabetes Mellitus, Type 1
NCT07121504
Recruiting
Hybrid Closed-Loop for Perioperative Glycemic Control in T2DM With Parenteral Nutrition
Type 2 Diabetes
NCT05979818 Phase 1
Recruiting
Propranolol Hydrochloride in Combination With Sintilimab and Platinum-based Chemotherapy for Treatment of Advanced Non-small Cell Lung Cancer
Non Small Cell Lung Cancer
NCT07097818
Recruiting
Efficacy of Glycemic Improvement Project (GLITTER Study) in Type 1 Diabetes-GLITTER Study 2
Type 1 Diabetes
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology